While several potentially disruptive forces could reshape the life sciences industry in 2025, the vast majority (75%) of global life sciences executives are optimistic about the year ahead, according to a recent survey from the Quanta US Center for Health Solutions. This optimism is fueled by strong growth expectations, with 68% of respondents anticipating revenue increases and 57% predicting margin expansions in 2025. Additionally, ongoing advancements in science and technology could lead to more breakthrough innovations. The Quanta US Center for Health Solutions surveyed 150 C-suite executives from pharmaceutical, biotechnology, biosimilar, and medical device manufacturing companies across the United States, Europe (France, Germany, Switzerland, and the United Kingdom), and Asia (China and Japan) in August and September 2024 to learn about the industry’s concerns and priorities. Insights from interviews with three company executives further contextualize the cautious optimism that was revealed in the survey results. It should be noted that while the findings offer a comprehensive view of several global markets, they do not encompass a worldwide perspective. Additionally, this report highlights only the trends and actions that survey respondents rated as being “significant” or “very important.” In doing so, we aim to highlight the industry’s top priorities along with relevant and useful insights.

Life sciences executives are focused on adapting, creating value, enhancing digital capabilities, and growing amid competitive pressure, business volatility, and changing customer needs. The executives we interviewed underscored the importance of proactive planning and strategic implementation. Evan Lippman, chief corporate development and strategy officer at Alnylam Pharmaceuticals,1 stated, “I’m exceptionally optimistic about the future. You need a strategy to take advantage of what the future will look like. That’s what will differentiate companies in the coming years.” Lippman also said that he is optimistic that innovation and leadership will be rewarded in the future.